KMT2A and leukemia: In a first instance, the transient silencing of KCTD15 in MLL-rearranged leukemia model systems (RS4;11 and SEM) induced cell death and apoptosis with a significant downregulation of pIKK-β, the kinase deputed to the activation of the NF-κB pathway9.